Blue Star Q1FY27 Investor Presentation Released
Blue Star Limited released its Q1FY27 investor presentation for the quarter ended June 30, 2026. Revenue declined 13% to ₹2337.8 crore, and EBITDA dropped 24% to ₹165 crore compared to Q1FY26. The company highlighted strong order bookings in data centers and continued international expansion.
The announcement provides a detailed financial and operational update for the quarter, including key performance indicators and segment-wise analysis. This information is material for investors to assess the company's current standing and future prospects, hence the medium impact.
The company released an investor presentation detailing its Q1FY27 performance. While some segments like data centers and international business show promise, the overall financial results indicate a decline in revenue and EBITDA compared to the previous year, with pressure on margins. The sentiment is neutral as it reflects both positive developments and financial challenges.
Blue Star Limited has released its Investor Presentation for the First Quarter ended June 30, 2026. This follows their previous communication on July 30, 2026.
The presentation details the company's performance across its business segments. In Electro-Mechanical Projects and Commercial Air Conditioning Systems, strong order bookings were driven by data centers, with continued growth prospects in this sector and factories. The Commercial Air Conditioning Systems segment saw increased order inflow supported by industrial, retail, and healthcare demand. The International Business expansion in the US is progressing well despite tariff uncertainties, with continued pursuit of customers in the US and Europe.
In Unitary Products, the Room Air Conditioner business achieved robust revenue growth, though margins faced pressure from rising input costs and Indian Rupee depreciation. The Commercial Refrigeration business experienced degrowth due to muted demand for deep freezers from Ice Cream OEMs.
The Professional Equipment and Industrial Solutions segment saw a decline primarily due to ongoing challenges in the Med Tech business, while Industrial Solutions grew steadily. The regulatory policy framework for Med-Tech Solutions remains unclear, impacting business momentum.
Financial highlights for Q1FY27 show a revenue of ₹2337.8 crore, a decrease of 13% from ₹2982 crore in Q1FY26. EBITDA stood at ₹165 crore, down 24% from ₹200 crore in Q1FY26. Earnings Per Share (EPS) was ₹4.99, down from ₹5.88 in the previous year. Profit Before Tax (PBT) was ₹126 crore, a decrease from ₹165 crore in Q1FY26.
The company also highlighted its ESG practices, focusing on environmentally responsible operations, social responsibility, community impact, and governance excellence. This includes eco-conscious product innovation, green infrastructure, sustainable manufacturing, circular economy initiatives, diversity and inclusion, CSR policy updates, skill development, education, health initiatives, and women empowerment. The company also emphasized its robust compliance framework, board diversity, and high disclosure standards, backed by industry recognitions.
What to do with a filing like this
Blue Star Limited filed this with the NSE as a statutory disclosure, categorised under investor presentation. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Blue Star Limited. Read the original for the full detail.